期刊文献+

反相微乳液法制备5-Fu磁性靶向药物及其释药性能 被引量:1

Preparation of 5-Fu Magnetic Targeting Drug in Inverse Microemulsion and study of Its Drug Release property
下载PDF
导出
摘要 以5-氟脲嘧啶(5-Fu)为模型药,壳聚糖(CS)为包覆材料,纳米四氧化三铁(Fe3O4)作为磁核,戊二醛为交联剂,通过反相微乳液制备5-Fu磁性靶向纳米微粒。最佳实验条件为:乳化剂用量为8%(v/v),壳聚糖浓度为1.5%(w/w),Fe3O4/CS为0.6(w/w),复合乳化剂的HLB值为6,5-Fu/CS为0.4(w/w),油水体积比为3:1,反应温度为55℃。磁性靶向药物的产率为83.06%、载药率为13.90%、包封率达到56.67%。通过模拟胃液(pH=1.8)和肠液(pH=7.6)做体外药物缓释实验。结果显示,在两种介质中,27小时内药物释放累积释药量分别为11.90%和10.23%,一定程度上达到了缓释、延长药效的目的。 Magnetic targeting drugs were prepared by using 5-fluorouracil (5-Fu) as model drug, Fe3 04 nanoparti-eles as magnetic nucleus, chitosan (CS) as enveloping material and glutaraldehyde as cross-linking agent through inverse microemulsion technique. The optimum conditions of synthesis are surfactant 8% (v/v), concentration of CS 1.5 % ( w/v), Fe3 tiCS O. 6, HLB 6,5-Fu/CS 0.4, volum ratio of oil/water 3 : 1, reacting temperature 55 ~C o The yield,drug loading and entrapment efficiency of magnetic targeting drug is 83.06% ,13.9% and 56.67% ,respec- tively. The cumulative release percent in the buffer solutions ( pH being of 1.8 and 7.6) are 11.90% and 10.23% in 27h ,respectively. The magnetic targeting drug could be released slowly and prolonged drug efficiently.
出处 《河北联合大学学报(自然科学版)》 CAS 2012年第1期62-66,共5页 Journal of Hebei Polytechnic University:Social Science Edition
基金 河北省教育厅青年基金项目(2011112)
关键词 5-FU 反相微乳液 磁性靶向 缓释 5-Fu Inverse microemulsion Magnetic targeting Slow-release
  • 相关文献

参考文献1

二级参考文献15

  • 1Kataoka,K.,Harada,A.,Nagasaki,Y.,"Block copolymer micelles for drug delivery:Design,characterization and biological significance",Adv.Drug Deliv.Rev.,47(1),113-131 (2001).
  • 2Han,S.K.,Na,K.,Bae,Y.H.,"Sulfonamide based pH-sensitive polymeric micelles:Physicochemical characteristics and pH-dependent aggregation",Colloids Surf.A:Physicochem.Eng.Aspects,214(1-3),49-59 (2003).
  • 3Fontana,G,Licciardi,M.,Mansueto,S.,Schillaci,D.,Giammona,G,"Amoxicillin-loaded polyethyl -cyanoacrylate nanoparticles:Influence of PEG coating on the particle size,drug release rate and phagocytic uptake",Biomaterials,22(21),2857-2865 (2001).
  • 4Stearne,L.E.T.,Schiffelers,R.M.,Smouter,E.,Bakker-Woudenberg,I.A.J.M.,Gyssens,I.C.,"Biodistribution of long-circulating PEG-liposomes in a murine model of established subcutaneous abscesses,BBA",Biomembranes,1561(1),91-97 (2002).
  • 5Duncan,R.,Gac-Breton,S.,Keane,R.,Musila,R.,Sat,Y.N.,Satchi,R.,Searle,F.,"Polymer-drug conjugates,PDEPT and PELT:Basic principles for design and transfer from the laboratory to clinic",J.Control.Release,74(1-3),135-146 (2001).
  • 6Li,C.,"Poly (L-glutamic acid)-anticancer drug conju gates",Adv.Drug Deliv.Rev.,54(5),695713 (2002).
  • 7Christie,R.J.,Grainger,D.W.,"Design strategies to improve soluble macromolecular delivery constructs",Adv.Drug Deliv.Rev.,55(3),421-437 (2003).
  • 8Putnam,D.,Kopecek,J.,"Polymer conjugates with anticancer activity",Adv.Polym.Sci.,122,55-123 (1995).
  • 9Kuen,Y.L.,Won,H.J.,"Structural determination and interior polarity of self-aggregates prepared from eoxycholic acid-modified chitosan in water",Macromolecules,31(2),378-383 (1998).
  • 10Jae,H.P.,Seunglee,K.,Ju-Ock,N.,Rang-Woon,P.,"Self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid for RGD peptide delivery",J.Control.Release,95(3),579-588 (2004).

共引文献6

同被引文献12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部